Permanent prostate brachytherapy-induced morbidity in patients with grade II and III obesity

Author： Merrick G.S.   Butler W.M.   Wallner K.   Galbreath R.W.   Anderson R.L.   Kurko B.S.   Lief J.H.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.60, Iss.1, 2002-07, pp. : 104-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Minimizing prostate brachytherapy-related morbidity

By Merrick G.S.   Wallner K.E.   Butler W.M.  

Urology, Vol. 62, Iss. 5, 2003-11 ,pp. : 786-792

Elsevier

Access to resources Recommend Favorite

Complications Following Permanent Prostate Brachytherapy

By Stone N.N.   Stock R.G.  

European Urology, Vol. 41, Iss. 4, 2002-04 ,pp. : 427-433

Elsevier

Access to resources Recommend Favorite

The Impact of Prostate Volume Following Neoadjuvant Androgen Deprivation on Quality of Life and Voiding Symptoms in Patients Undergoing Permanent Prostate Brachytherapy

By Krupski T.   Bissonette E.A.   Petroni G.R.   Theodorescu D.  

European Urology, Vol. 43, Iss. 5, 2003-05 ,pp. : 467-472

Elsevier

Access to resources Recommend Favorite

Biochemical outcome for hormone-naive patients with Gleason score 3+4 versus 4+3 prostate cancer undergoing permanent prostate brachytherapy

By Merrick G.S.   Butler W.M.   Galbreath R.W.   Lief J.H.   Adamovich E.  

Urology, Vol. 60, Iss. 1, 2002-07 ,pp. : 98-103

Elsevier

Access to resources Recommend Favorite

Importance of Post-Implant Dosimetry in Permanent Prostate Brachytherapy

By Stock R.G.   Stone N.N.  

European Urology, Vol. 41, Iss. 4, 2002-04 ,pp. : 434-439

Elsevier

Access to resources Recommend Favorite